rapamycin


Also found in: Dictionary, Wikipedia.

rapamycin

(răp′ə-mī′sĭn)
n.

sirolimus

A macrolide immunosuppressant that is structurally similar to tacrolimus. It suppresses B- and T-cell proliferation, lymphokine synthesis, and T-cell response to IL2 by acting on target of rapamycin (TOR).

rapamycin

Sirolimus, see there.
References in periodicals archive ?
The company holds the exclusive license to eRapa, an improved, targeted formulation of rapamycin originally developed at UT Health San Antonio that is being investigated to prevent cancer and other age-related medical conditions.
Researchers showed that rapamycin worked by activating a protein quality-control pathwaythe autophagy pathwayin cells.
"The biological aging process is very similar in dogs and people," says University of Washington researcher Matt Kaeberlein, who is spearheading the rapamycin studies.
The enzyme mammalian (or mechanistic) target of rapamycin (mTOR) plays a key role in the control of crucial cell processes; it regulates growth and keeps it in a state of equilibrium.
The phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway is one of the bridges that link intracellular and extracellular signal transduction and cell response.
Mary Kay Koenig, M.D., from The University of Texas Health Science Center at Houston, and colleagues examined the efficacy and safety of topical rapamycin for TSC-related facial angiofibromas in a study involving 179 patients.
Added to patient-derived cells in culture, rapamycin enabled the development of more Purkinje precursor cells, improved the functioning of their synapses and increased their tendency to fire.
Rapamycin inhibits mTORC1 by binding the 12 kDa intracellular FK506-binding protein (FKBP12) that in turn directly interacts with mTORC1 but not with mTORC2 [7].
I don't know if, 5 years from now, we'll all be taking low-dose rapamycin as an antiaging drug, but we might, especially if someone figures out the ideal dose," he said at the Hawaii Dermatology Seminar provided by Global Academy for Medical Education/Skin Disease Research Foundation.
In this study, fibroblasts from MADB patients exhibited marked nuclear abnormalities and reduced proliferation that improved upon treatment with rapamycin and dimethylsulfoxide but not with other agents, including farnesyl transferase inhibitors.
A compound called rapamycin may actually be able to postpone aging and death, according to the (https://www.technologyreview.com/s/603997/is-this-the-anti-aging-pill-weve-all-been-waiting-for/?set=603998) MIT Technology Review .
Bafilomycin A1, rapamycin, and FlowCellect[TM] Autophagy LC3 Antibody-based Assay kits (FITC) were purchased from Merck Millipore, Billerica, MA.